Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Function”

597 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 597 results

Very early researchUnknownNCT03673215
What this trial is testing

The Tolerability，Safety，PK/PD Study of rhTPO in the Patients With Liver Function Impairment

Who this might be right for
Liver Cirrhosis
Shenyang Sunshine Pharmaceutical Co., LTD. 58
Not applicableActive Not RecruitingNCT05065593
What this trial is testing

The Effect of Aerobic and Resistant Exercise Training in Patients With Non-Alcoholic Steatohepatitis

Who this might be right for
Non-Alcoholic Steatohepatitis
Hacettepe University 26
Not applicableStudy completedNCT00528138
What this trial is testing

Hyperbilirubinemia in Acute Appendicitis as a Predictor of Perforation

Who this might be right for
Perforated Appendicitis
Cirujanos la Serena 132
Early research (Phase 1)Study completedNCT02536911
What this trial is testing

The Effects of Hepatic Impairment on the Pharmacokinetics and Tolerability of Eliglustat Tartrate

Who this might be right for
Gaucher Disease
Genzyme, a Sanofi Company 24
Not applicableStudy completedNCT02336191
What this trial is testing

Monitoring Living Donor Liver Functions by Thromboelastometry

Who this might be right for
THROMBELASTOGRAPHY and Liver Graft Functions
Mansoura University 50
Early research (Phase 1)Study completedNCT01919125
What this trial is testing

Pharmacokinetics of IDX719 in Participants With Normal and Impaired Hepatic Function (MK-1894-008)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 36
Not applicableStudy completedNCT00305591
What this trial is testing

Brain Imaging in Patients With Chronic Liver Disease and Functional Impairment.

Who this might be right for
CirrhosisHepatic Encephalopathy
Imperial College London 50
Early research (Phase 1)Study completedNCT06106113
What this trial is testing

Pharmacokinetics and Safety of GST-HG171 Tablets in Subjects With Impaired and Normal Liver Function

Who this might be right for
COVID-19 Pneumonia
Fujian Akeylink Biotechnology Co., Ltd. 24
Large-scale testing (Phase 3)WithdrawnNCT04128462
What this trial is testing

MNK-6105 for Patients With Cirrhosis and High Ammonia Levels Affecting Brain Function

Who this might be right for
Hepatic Encephalopathy
Mallinckrodt
Not applicableWithdrawnNCT02356250
What this trial is testing

A Pilot Study: Defining Peripheral Endothelial Function in Portal Hypertensive Cirrhotic Patients

Who this might be right for
Portal HypertensionCirrhosis
Eyal Ashkenazi
Testing effectiveness (Phase 2)Study completedNCT03349697
What this trial is testing

Phyllantus Amarus for the Protection of Liver Health

Who this might be right for
Healthy
Biotropics Malaysia Berhad 15
Early research (Phase 1)Looking for participantsNCT06376474
What this trial is testing

To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage

Who this might be right for
Psoriasis
Ganzhou Hemay Pharmaceutical Co., Ltd 24
Early research (Phase 1)UnknownNCT00935454
What this trial is testing

Hepatocyte Matrix Implant Study

Who this might be right for
Liver DiseaseLiver Cirrhosis
Baermed 10
Testing effectiveness (Phase 2)Study completedNCT00423592
What this trial is testing

Phase 2 Study of Ambrisentan for Liver Function Test Rescue in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Hypertension
Gilead Sciences 36
Early research (Phase 1)Looking for participantsNCT06952634
What this trial is testing

An Investigational Study of ESK-001 in Participants With Normal Liver Function and Participants With Mild, Moderate, and Severe Liver Damage

Who this might be right for
Hepatic Impairment
Alumis Inc 48
Early research (Phase 1)Looking for participantsNCT06740799
What this trial is testing

Assessment of Quizartinib Pharmacokinetic in Subjects With Severe Hepatic Impairment

Who this might be right for
Hepatic Impairment
Daiichi Sankyo 12
Early research (Phase 1)Study completedNCT02894385
What this trial is testing

Effect of Hepatic and Renal Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1841788 (ODM-201)

Who this might be right for
PharmacokineticsHepatic InsufficiencyRenal Insufficiency
Bayer 29
Testing effectiveness (Phase 2)Ended earlyNCT01875874
What this trial is testing

Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)

Who this might be right for
Acute Liver FailureFulminant Hepatic FailurePrimary Graft Non-Function+1 more
Vital Therapies, Inc. 8
Not applicableStudy completedNCT02010034
What this trial is testing

Compassionate Use of Omegaven in the Treatment of Parenteral Nutrition Induced Hepatic Injury

Who this might be right for
Liver DiseaseImpaired Liver FunctionParenteral Nutrition Associated Liver Disease
Children's Medical Center Dallas 15
Large-scale testing (Phase 3)Study completedNCT00244569
What this trial is testing

Development of a Breath Test for Monitoring Patients With Liver Disease

Who this might be right for
Fatty LiverCirrhosis
Virginia Commonwealth University 120
Load More Results